Why the study?
Does carvedilol improve left ventricular function, remodeling, and survival in rats surviving a large myocardial infarction?
Does carvedilol improve left ventricular function, remodeling, and survival in rats surviving a large myocardial infarction?
In a rat model of large myocardial infarction, high-dose carvedilol preserved LV function and reduced fibrosis but paradoxically increased early mortality.
Answers are grounded in this paper and cite their sources.
Alerts to potential harm from high-dose carvedilol post-MI in rats; leaves open dose optimization for survival benefit in preclinical models.
Carvedilol (20 mg/kg, bid) or vehicle was given to rats surviving a myocardial infarction (MI) 24 h (n = 409). In rats with large MI, carvedilol partially preserved left ventricular (LV) function and intrinsic myocardial contractility and reactivity to beta-adrenergic stimulation. Carvedilol led to scar thickening, increased LV hypertrophy, and decreased cardiac fibrosis but did not prevent LV dilatation. Carvedilol reduced cardiac expression of interleukin-1beta but did not prevent cardiac fetal gene re-expression or modify cardiac oxidative stress. Despite these beneficial effects, carvedilol decreased survival (38.8%, versus vehicle, 50.6%) due to excessive early mortality. Thus, post-MI carvedilol has many beneficial effects, however, in this study it increased post-MI mortality, perhaps due to excessive hypotension.
No takes yet. Share an insight, caveat, or question.
Sia et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: